Pure Global

Clinical Trial - Trial ChiCTR2200062210

Access comprehensive clinical trial information for ChiCTR2200062210 through Pure Global AI's free database. This Phase 1 trial is sponsored by General Hospital of Ningxia Medical University and is currently Recruiting. The study focuses on colorectal cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200062210
Phase 1
Recruiting
Trial Details
Chinese Clinical Trial Registry โ€ข ChiCTR2200062210
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Risk Factors for Postoperative Intensive Care Unit Admission after Colorectal Cancer Surgery.

Study Focus

colorectal cancer

Sponsor & Location

General Hospital of Ningxia Medical University

National Natural Science Foundation of China

China

Timeline & Enrollment

Phase 1

N/A

May 15, 2023

ICD-10 Classifications

Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon

Data Source

Chinese Clinical Trial Registry

ChiCTR2200062210

Non-Device Trial